+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Leukapheresis Market by Product, Leukopak, Application, End User - Global Forecast to 2023

  • ID: 4607758
  • Report
  • August 2018
  • Region: Global
  • 185 Pages
  • Markets and Markets
1 of 5
The Leukapheresis Products Market is Expected to Reach USD 27.7 Million by 2023 From an Estimated USD 19.4 Million in 2018, at a CAGR of 7.4%.

FEATURED COMPANIES

  • ALLCells, LLC.
  • Caltag Medsystems Limited
  • Haemonetics Corporation
  • Key Biologics, LLC.
  • PPA Research Group, Inc.
  • Terumo BCT
  • MORE

The leukapheresis products and leukopaks markets are projected to grow at a CAGR of 7.4% and 46.4%, respectively.
 
The leukapheresis products market is expected to reach USD 27.7 million by 2023 from an estimated USD 19.4 million in 2018, at a CAGR of 7.4%. The leukopaks market is expected to reach USD 445.6 million by 2023, at a CAGR of 46.4%. Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis and leukopaks and stringent donor recruitment criteria are restraining the growth of this market to a certain extent.

The leukoreduction filters segment is expected to register the highest CAGR during the forecast period.

By type, the leukapheresis products market is segmented into leukapheresis devices and leukapheresis disposables. The leukapheresis devices segment is further subsegmented into apheresis devices, leukapheresis columns & cell separators, and leukoreduction filters. The leukoreduction filters segment is expected to register the highest CAGR during the forecast period. This high growth-rate can be attributed to the increasing adoption of leukoreduction filters by researchers.

The isolated PBMCs segment is expected to register the highest CAGR during the forecast period.

On the basis of type, the leukopaks market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. The isolated PBMCs segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the increasing focus of researchers on cell-based therapies including CAR-T therapy targeted development.

Asia Pacific is projected to witness the highest growth during the forecast period.

In 2017, the Asia Pacific accounted for the largest share of the global leukapheresis market. This regional segment is also estimated to grow at the highest CAGR during the forecast period. The presence of a large number of pharma and biotech companies and research institutes in China and India and improving life science research infrastructure in several APAC countries are the major factors driving the growth of this regional market.

Break of primary participants was as mentioned below:

  • By Company Type – Tier 1–46%, Tier 2–33% and Tier 3–21%
  • By Designation – C-level–43%, Director Level–35%, Others–22%
  • By Region – North America–34%, Europe–26%, Asia Pacific–24%, RoW–16%

Research Coverage:

The report analyzes the various leukapheresis products & leukopaks and their adoption patterns. It aims to estimate the market size and future growth potential of the global leukapheresis products market for different segments such as type, application, end user, and region. It also aims at estimating the market size and growth potential of the global leukoapks market for different segments such as type, indication, end user, and region. The report also includes an in-depth competitive analysis of key players in this market along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global leukapheresis market
  • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global leukapheresis market
  • Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global leukapheresis market
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ALLCells, LLC.
  • Caltag Medsystems Limited
  • Haemonetics Corporation
  • Key Biologics, LLC.
  • PPA Research Group, Inc.
  • Terumo BCT
  • MORE

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Leukapheresis Products Market
       4.1.1 Leukapheresis Products Market: Overview
       4.1.2 Leukapheresis Products Market, By End User & Region (2017)
       4.1.3 Geographic Snapshot of the Leukapheresis Products Market (2017)
       4.1.4 Geographic Mix: Leukapheresis Products Market, 2018–2023 (USD Million)
       4.1.5 Leukapheresis Products Market: Developing vs Developed Markets, 2018 vs 2023 (USD Million)
4.2 Leukopaks Market
       4.2.1 Leukopaks Market: Overview
       4.2.2 Leukopaks Market, By Type & Region (2017)
       4.2.3 Geographic Snapshot of the Leukopaks Market (2017)
       4.2.4 Geographic Mix: Leukopaks Market, 2018–2023 (USD Million)
       4.2.5 Leukopaks Market: Developing vs Developed Markets, 2018 vs 2023 (USD Million)

5 Market Overview

5.1 Introduction
5.2 Market Dynamics: Impact Analysis
       5.2.1 Market Drivers
                5.2.1.1 Increasing Incidence and Prevalence of Leukemia
                5.2.1.2 Increasing Number of Blood Donations
                5.2.1.3 Demand for Leukopaks in Clinical Research
       5.2.2 Market Restraints
                5.2.2.1 High Cost of Therapeutic Leukapheresis and Leukopaks
                5.2.2.2 Stringent Donor Recruitment Criteria
                5.2.2.3 Dearth of Skilled Professionals and Low Adoption of Therapeutic Leukapheresis
                5.2.2.4 Complications Associated With Therapeutic Leukapheresis
       5.2.3 Market Opportunities
                5.2.3.1 Leukapheresis for Pediatric Patients
                5.2.3.2 Emerging Economies and Increasing Investments From Academic Institutes, Pharma-Biotech Companies, and Leading Players
       5.2.4 Market Challenges
                5.2.4.1 High Cost of Cellular Immunotherapies
                5.2.4.2 Blood Transfusion Safety in Developing Countries

6 Industry Insights

6.1 Industry Trends
       6.1.1 Increasing Number of Collaborations Among Pharma and Biotech Companies
6.2 Leukopaks: Pricing Analysis
6.3 Regulatory Analysis
       6.3.1 US
       6.3.2 Europe
       6.3.3 Japan

7 Leukapheresis Products Market, By Type

7.1 Introduction
7.2 Leukapheresis Devices
       7.2.1 Apheresis Devices
       7.2.2 Leukapheresis Columns & Cell Separators
       7.2.3 Leukoreduction Filters
7.3 Leukapheresis Disposables

8 Leukapheresis Products Market, By Application

8.1 Introduction
8.2 Research Applications
8.3 Therapeutic Applications

9 Leukapheresis Products Market, By End User

9.1 Introduction
9.2 Blood Component Providers and Blood Centers
9.3 Academic and Research Institutes
9.4 Pharmaceutical and Biotechnology Companies
9.5 Hospitals and Transfusion Centers

10 Leukopaks Market

10.1 Introduction
10.2 Leukopaks Market, By Type
        10.2.1 Mobilized Peripheral Blood Leukopaks
        10.2.2 Non-Mobilized Peripheral Blood Leukopaks
        10.2.3 Diseased Leukopaks
        10.2.4 Isolated Pbmcs
10.3 Leukopaks Research Application Market, By Indication
10.4 Leukopaks Market, By End User
        10.4.1 Introduction
        10.4.2 Academic & Research Institutes
        10.4.3 Pharmaceutical and Biotechnology Companies
        10.4.4 Contract Research Organizations

11 Geographic Analysis

11.1 Introduction
11.2 North America
        11.2.1 US
        11.2.2 Canada
11.3 Europe
        11.3.1 UK
        11.3.2 Germany
        11.3.3 Spain
        11.3.4 RoE
11.4 Asia Pacific
        11.4.1 China
        11.4.2 Japan
        11.4.3 Rest of Asia Pacific
11.5 Rest of the World

12 Competitive Landscape

12.1 Introduction
12.2 Product Portfolio Matrix
12.3 Market Share Analysis
        12.3.1 Leukapheresis Products
        12.3.2 Leukopaks
12.4 Competitive Situations and Trends
        12.4.1 Product Launches and Enhancements
        12.4.2 Agreements, Partnerships, and Collaborations
        12.4.3 Mergers and Acquisitions
        12.4.4 Expansions

13 Company Profiles

13.1 Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
13.2 Fresenius Se & Co. KGaA
13.3 Haemonetics Corporation
13.4 Hemacare Corporation
13.5 Key Biologics, LLC.
13.6 Terumo BCT
13.7 ALLCells, LLC.
13.8 Stemexpress, LLC.
13.9 Stemcell Technologies, Inc.
13.10 Caltag Medsystems Limited
13.11 Zenbio, Inc.
13.12 Precision for Medicine, Inc.
13.13 PPA Research Group, Inc.
13.14 Bioivt
13.15 Macopharma SA

14 Appendix

List of Tables

Table 1 Standard Currency Conversion Rates
Table 2 Incidence of Leukemia, By Country
Table 3 Collection of Whole Blood Units, By Country, 2015–2016 (Million Units)
Table 4 Cost of Leukopaks, By Type
Table 5 Donor Selection Criteria
Table 6 Frequency of Blood Donations From Healthy Donations
Table 7 Recent Initiatives for Development of Car T Therapy
Table 8 Recent Pharma-Biotech Collaborations for Development of Car T Therapy
Table 9 Asp of Non-Mobilized Leukopaks
Table 10 Asp of Mobilized Leukopaks
Table 11 Asp of Mobilized Isolated Cells
Table 12 List of Fda Approved Car T Therapeutics
Table 13 Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 14 Leukapheresis Products Market, By Country, 2016–2023 (USD Million)
Table 15 Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 16 Leukapheresis Devices Market, By Country, 2016–2023 (USD Million)
Table 17 Leading Manufacturers Offering Apheresis Devices
Table 18 Apheresis Devices Market, By Country, 2016–2023 (USD Million)
Table 19 Leading Manufacturers of Leukapheresis Columns & Cell Separators
Table 20 Leukapheresis Columns & Cell Separators Market, By Country, 2016–2023 (USD Million)
Table 21 Leading Manufacturers of Leukoreduction Filters
Table 22 Leukoreduction Filters Market, By Country, 2016–2023 (USD Million)
Table 23 Leukapheresis Disposables Market, By Country, 2016–2023 (USD Million)
Table 24 Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 25 Number of Clinical Trials Based on Car T-Cell Therapy, 2013 to 2017
Table 26 Leukapheresis Products Market for Research Applications, By Country, 2016–2023 (USD Million)
Table 27 Leukapheresis Products Market for Therapeutic Applications, By Country, 2016–2023 (USD Thousand)
Table 28 Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 29 Leukapheresis Products Market for Blood Component Providers and Blood Centers, By Country, 2016–2023 (USD Million)
Table 30 Leukapheresis Products Market for Academic and Research Institutes, By Country, 2016–2023 (USD Million)
Table 31 Leading Pharma-Biotech Companies Involved in the Development of Car-T Technologies
Table 32 Leukapheresis Products Market for Pharmaceutical and Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 33 Number of Hospitals Performing Blood Transfusions, By Region, 2015
Table 34 Leukapheresis Products Market for Hospitals and Transfusion Centers, By Country, 2016–2023 (USD Million)
Table 35 Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 36 Leukopaks Market, By Country, 2016–2023 (USD Million)
Table 37 Mobilized Pb Leukopaks Market, By Country, 2016–2023 (USD Million)
Table 38 Comparative Analysis of Mobilized Pb Leukopaks and Non-Mobilized Pb Leukopaks
Table 39 Non-Mobilized Pb Leukopaks Market, By Country, 2016–2023 (USD Million)
Table 40 Diseased Leukopaks Market, By Country, 2016–2023 (USD Million)
Table 41 Isolated Pbmcs Market, By Country, 2016–2023 (USD Million)
Table 42 Leukopaks Research Application Market, By Indication, 2016–2023 (USD Million)
Table 43 Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 44 Leukopaks Market for Academic and Research Institutes, By Country, 2016–2023 (USD Million)
Table 45 Leukopaks Market for Pharmaceutical and Biotechnology Companies, By Country, 2016–2023 (USD Million)
Table 46 Leukopaks Market for Contract Research Organizations, By Country, 2016–2023 (USD Million)
Table 47 Leukapheresis Products Market, By Region, 2016–2023 (USD Million)
Table 48 Leukopaks Market, By Region, 2016–2023 (USD Million)
Table 49 North America: Leukapheresis Products Market, By Country, 2016–2023 (USD Million)
Table 50 North America: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 51 North America: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 52 North America: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 53 North America: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 54 North America: Leukopaks Market, By Country, 2016–2023 (USD Million)
Table 55 North America: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 56 North America: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 57 US: Key Macroindicators
Table 58 US: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 59 US: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 60 US: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 61 US: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 62 US: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 63 US: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 64 Canada: Key Macroindicators
Table 65 Canada: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 66 Canada: Leukapheresis Devices Market, By Type, 2016–2023 (USD Thousand)
Table 67 Canada: Leukapheresis Products Market, By Application, 2016–2023 (USD Thousand)
Table 68 Canada: Leukapheresis Products Market, By End User, 2016–2023 (USD Thousand)
Table 69 Canada: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 70 Canada: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 71 Europe: Number of Registered Car Therapy Clinical Trials, By Country, 2013–2017
Table 72 Europe: Leukapheresis Products Market, By Country, 2016–2023 (USD Million)
Table 73 Europe: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 74 Europe: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 75 Europe: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 76 Europe: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 77 Europe: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 78 Europe: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 79 UK: Key Macroindicators
Table 80 UK: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 81 UK: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 82 UK: Leukapheresis Products Market, By Application, 2016–2023 (USD Thousand)
Table 83 UK: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 84 Germany: Key Macroindicators
Table 85 Germany: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 86 Germany: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 87 Germany: Leukapheresis Products Market, By Application, 2016–2023 (USD Thousand)
Table 88 Germany: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 89 Spain: Key Macroindicators
Table 90 Spain: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 91 Spain: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 92 Spain: Leukapheresis Products Market, By Application, 2016–2023 (USD Thousand)
Table 93 Spain: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 94 RoE: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 95 RoE: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 96 RoE: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 97 RoE: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 98 APAC: Leukapheresis Products Market, By Country, 2016–2023 (USD Million)
Table 99 APAC: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 100 APAC: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 101 APAC: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 102 APAC: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 103 APAC: Leukopaks Market, By Country, 2016–2023 (USD Million)
Table 104 APAC: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 105 APAC: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 106 China: Key Macroindicators
Table 107 China: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 108 China: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 109 China: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 110 China: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 111 China: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 112 China: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 113 Japan: Key Macroindicators
Table 114 Japan: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 115 Japan: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 116 Japan: Leukapheresis Products Market, By Application, 2016–2023 (USD Thousand)
Table 117 Japan: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 118 RoAPAC: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 119 RoAPAC: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 120 RoAPAC: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 121 RoAPAC: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 122 RoAPAC: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 123 RoAPAC: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 124 RoW: Leukapheresis Products Market, By Type, 2016–2023 (USD Million)
Table 125 RoW: Leukapheresis Devices Market, By Type, 2016–2023 (USD Million)
Table 126 RoW: Leukapheresis Products Market, By Application, 2016–2023 (USD Million)
Table 127 RoW: Leukapheresis Products Market, By End User, 2016–2023 (USD Million)
Table 128 RoW: Leukopaks Market, By Type, 2016–2023 (USD Million)
Table 129 RoW: Leukopaks Market, By End User, 2016–2023 (USD Million)
Table 130 Growth Strategy Matrix
Table 131 Product Launches and Enhancements (2015 –June 2018)
Table 132 Agreements, Partnerships, and Collaborations (2015–June 2018)
Table 133 Mergers and Acquisitions (2015–June 2018)
Table 134 Expansions (2015–June 2018)

List of Figures

Figure 1 Research Design
Figure 2 Primary Sources
Figure 3 Breakdown of Primary Interviews (Supply Side): By Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews (Demand Side): By End User, Designation, and Region
Figure 5 Data Triangulation Methodology
Figure 6 Leukapheresis Disposables to Dominate the Leukapheresis Products Market During the Forecast Period
Figure 7 Apheresis Devices to Dominate the Leukapheresis Devices Market During the Forecast Period
Figure 8 Research Applications to Register Highest Growth in the Leukapheresis Products Market During the Forecast Period
Figure 9 Blood Component Providers & Blood Centers to Account for the Largest Share of the Leukapheresis Products Market in 2018
Figure 10 Mobilized Pb Leukopaks to Dominate the Leukopaks Market During 2018–2023
Figure 11 Acute Lymphocytic Leukemia to Dominate the Leukopaks Research Application Market, By Indication, During the Forecast Period
Figure 12 Academic & Research Institutes to Register Highest Growth in the Leukopaks Market During the Forecast Period
Figure 13 Geographic Snapshot: Leukapheresis Products Market
Figure 14 Geographic Snapshot: Leukopaks Market
Figure 15 Increasing Adoption of Therapeutic Leukapheresis Procedures to Drive Market Growth
Figure 16 Blood Component Providers & Blood Centers Held the Largest Share of the Leukapheresis Market in 2017
Figure 17 The US Accounted for the Largest Share of the Leukapheresis Products Market in 2017
Figure 18 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 19 Developing Markets to Register Higher Growth During the Forecast Period
Figure 20 Growing Number of Clinical Trials for the Development of Car-T Therapies to Drive Market Growth
Figure 21 Mobilized Leukopaks Held the Largest Share of the Leukopaks Market in 2017
Figure 22 The US Accounted for the Largest Share of the Leukopaks Market in 2017
Figure 23 APAC to Grow at the Highest CAGR During the Forecast Period
Figure 24 Developing Markets to Register Higher Growth During the Forecast Period
Figure 25 Growth in Number of Immunotherapy Trials
Figure 26 Leukapheresis Disposables to Dominate the Leukapheresis Products Market During the Forecast Period
Figure 27 Apheresis Devices Dominated the Leukapheresis Products Market in 2017
Figure 28 Research Applications to Dominate the Leukapheresis Products Market From 2018 to 2023
Figure 29 Blood Component Providers and Blood Centers Estimated to Be the Largest End Users of Leukapheresis Products During the Forecast Period
Figure 30 Mobilized Pb Leukopaks Segment Will Continue to Dominate the Leukopaks Market During the Forecast Period
Figure 31 Number of Car-T Cell Therapy Clinical Trials Across the Globe
Figure 32 Acute Lymphocytic Leukemia Segment Dominated the Leukopaks Research Application Market in 2018
Figure 33 Academic & Research Institutes Segment to Register the Highest CAGR During the Forecast Period
Figure 34 Leukapheresis Products Market: Geographic Growth Opportunities
Figure 35 Leukopaks Market: Geographic Growth Opportunities
Figure 36 North America: Leukapheresis Products Market Snapshot
Figure 37 North America: Leukopaks Market Snapshot
Figure 38 Number of Registered Car Therapy Clinical Trials in the Us, 2013–2017
Figure 39 APAC: Leukapheresis Products Market Snapshot
Figure 40 APAC: Leukopaks Market Snapshot
Figure 41 Key Developments of Major Players Between 2014 and 2017
Figure 42 Leukapheresis Products Market Share Analysis, By Key Player, 2017
Figure 43 Leukopaks Market Share Analysis, By Key Player, 2017
Figure 44 Asahi Kasei Corporation: Company Snapshot (2017)
Figure 45 Fresenius Medical Care: Company Snapshot (2017)
Figure 46 Fresenius Kabi: Company Snapshot (2017)
Figure 47 Haemonetics Corporation: Company Snapshot (2018)
Figure 48 Hemacare Corporation: Company Snapshot (2017)
Figure 49 Terumo BCT: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Asahi Kasei Medical Co., Ltd. (A Subsidiary of Asahi Kasei Corporation)
  • Fresenius Se & Co. KGaA
  • Haemonetics Corporation
  • Hemacare Corporation
  • Key Biologics, LLC.
  • Terumo BCT
  • ALLCells, LLC.
  • Stemexpress, LLC.
  • Stemcell Technologies, Inc.
  • Caltag Medsystems Limited
  • Zenbio, Inc.
  • Precision for Medicine, Inc.
  • PPA Research Group, Inc.
  • Bioivt
  • Macopharma SA
Note: Product cover images may vary from those shown
Adroll
adroll